Skip to main content

$3.33 0.01 (0.30%)

High

$3.34

Low

$3.32

Trades

122

Turnover

$518,004

Volume

155,585
30 June 2023 at 4:10pm
Register to track SLA and receive email alerts.
SLA Announcements on Price Chart

Latest Announcements

Headline Date
Becoming a substantial holder 28 June 2023 at 6:25pm
Wesfarmers Health and SILK enter Scheme Implementation Deed 26 June 2023 at 9:55am
SILK Enters into Binding Implementation Deed with API 26 June 2023 at 9:55am
Ceasing to be a substantial holder from WAM, WMI, WAX 9 June 2023 at 5:30pm
Change in substantial holding 6 June 2023 at 5:30pm
Change in substantial holding from WAM, WMI, WAX 6 June 2023 at 5:25pm
Expiry of Process Deed and Intention to Recommend Proposal 2 June 2023 at 10:20am
Notice of ceasing to be a substantial holder from WES 1 June 2023 at 4:25pm
API Does Not Exercise Matching Rights Under Process Deed 30 May 2023 at 9:55am
Superior Proposal from EC Healthcare 23 May 2023 at 9:35am
Notice of initial substantial holder from WES 19 April 2023 at 7:50pm
WES: Wesfarmers Health proposal to acquire SILK Laser Aust 19 April 2023 at 7:50pm
Non-Binding Indicative Acquisition Proposal From API 19 April 2023 at 7:40pm
Change of Director's Interest Notice - Martin Perelman 31 March 2023 at 6:25pm
Notification regarding unquoted securities - SLA 31 March 2023 at 5:25pm
Change in substantial holding 6 March 2023 at 9:10am
SILK completes acquisition of Eden Laser Clinics 2 March 2023 at 8:35am
SILK delivers another half of revenue and earnings growth 28 February 2023 at 8:35am
SILK H1 FY23 Results Presentation 28 February 2023 at 8:30am
Appendix 4D & FY23 Half-Year Financial Statements 28 February 2023 at 8:30am
H1 FY23 Results and Investor Briefing Details 3 February 2023 at 2:05pm
SILK to expand NSW footprint with acquisition of Eden Laser 22 December 2022 at 9:20am
New Constitution 28 November 2022 at 8:40am
2022 AGM - Results of Meeting 22 November 2022 at 2:40pm
2022 AGM Presentation 22 November 2022 at 10:50am
Notice of 2022 Annual General Meeting and Proxy Form 21 October 2022 at 9:10am
Corporate Governance Statement & Appendix 4G 30 September 2022 at 6:05pm
2022 Corporate Governance Statement & Appendix 4G 30 September 2022 at 5:20pm
2022 Annual Report 29 September 2022 at 7:50pm
Date of AGM and Closing Date For Director Nominations 19 September 2022 at 8:45am
Change of Director's Interest Notice - Sinead Ryan 5 September 2022 at 1:45pm
Change of Director's Interest Notice - Jacinta Caithness 5 September 2022 at 10:55am
Change of Director's Interest Notice - Boris Bosnich 31 August 2022 at 4:20pm
Notice under Section 708A(5) of the Corporations Act 31 August 2022 at 4:10pm
Application for quotation of securities - SLA 31 August 2022 at 4:10pm
Notification of cessation of securities - SLA 31 August 2022 at 4:10pm
Application for quotation of securities - SLA 31 August 2022 at 4:05pm
FY22 Results Investor Presentation 30 August 2022 at 8:25am
SILK Beats FY22 Guidance, Continues Growth Trajectory 30 August 2022 at 8:25am
Appendix 4E & Preliminary Financial Report - 30 June 2022 30 August 2022 at 8:25am
Change of Director's Interest Notice - Martin Perelman 29 August 2022 at 10:40am
Notification regarding unquoted securities - SLA 26 August 2022 at 8:20am
Release from Voluntary Escrow 23 August 2022 at 2:15pm
FY22 Results and Investor Briefing Details 17 August 2022 at 9:50am
SILK launches Australian-first day procedure centres in Tas 26 July 2022 at 8:45am
SILK acquires Unique Laser - additional information 19 July 2022 at 7:35pm
SILK acquires Unique Laser, expands network to 128 clinics 18 July 2022 at 9:40am
SILK on track for $20M EBITDA, ahead of analyst consensus 28 April 2022 at 8:50am
Initial Director's Interest Notice - Jacinta Caithness 27 April 2022 at 4:45pm
Final Director's Interest Notice - Bradley Lynch 27 April 2022 at 4:45pm
Register to track SLA and receive email alerts.